UPDATE : Tuesday, July 7, 2020
상단여백
Sanofi releases hemophilia A treatment
Sanofi Aventis Korea said Tuesday that it was launching a hemophilia A trea...
by Shim Hyun-tai  |  2020-06-16 17:27
라인
Sillajen CEO steps down
Sillajen CEO Moon Eun-sang has resigned from his post.Moon’s resignation ca...
by Lee Han-soo  |  2020-06-16 16:49
라인
MSD fails to present plausible reasons, grounds for discriminating against branches
Last Thursday, MSD Korea's labor union took issue with the expanded imp...
by Lee Han-soo  |  2020-06-16 16:21
라인
Gemvax & Kael's GV1001 shows efficacy as hepatitis B treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo  |  2020-06-16 16:18
라인
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
Takeda Pharmaceutical’s sell-off of part of its business to Celltrion is ex...
by Kim Yun-mi  |  2020-06-16 11:44
라인
Jardiance family of diabetes drugs sells ₩10 billion in Q1
The Jardiance family of diabetes drugs, including Jardiance (empagliflozin)...
by Kim Yun-mi  |  2020-06-15 17:39
라인
Biogen’s FDA application for Alzheimer’s drug drags on
Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S...
by Kim Yun-mi  |  2020-06-15 12:09
라인
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
About 60 percent of workers in the domestic pharmaceutical industry predict...
by Shim Hyun-tai  |  2020-06-12 17:56
라인
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
PharmAbcine, an antibody new drug developer, has signed a CDMO (contract de...
by Lee Han-soo  |  2020-06-12 17:15
라인
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
Pharmicell said that the Ministry of Food and Drug Safety has approved its ...
by Lee Han-soo  |  2020-06-12 16:07
라인
Takeda’s sell-off of primary care biz to Celltrion triggers union protest
Celltrion said that it has acquired the business rights for 18 brands of Ta...
by Lee Han-soo  |  2020-06-12 15:32
라인
GC LabCell releases clinical results of NK cell therapy
GC LabCell has unveiled the study data of the combined therapy of its natur...
by Shim Hyun-tai  |  2020-06-11 17:34
라인
Genexine to start P1 trial of Covid-19 treatment in US
Genexine said NeoImmuneTech, its U.S. affiliate, has received approval from...
by Lee Han-soo  |  2020-06-11 16:26
라인
MSD Korea’s trade union refuses to use controversial monitoring program
The labor union of MSD Korea went up and arms about the company’s enhanced ...
by Kim Yun-mi  |  2020-06-11 14:31
라인
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
Clinical results have shown that AstraZeneca's Imfinzi may be an effect...
by Lee Han-soo  |  2020-06-10 17:58
라인
‘Abbvie’s psoriasis drug proves long-term treatment effect’
Abbvie's Skyrizi (ingredient: risankizumab) showed the best treatment e...
by Shim Hyun-tai  |  2020-06-10 15:59
라인
Baekje to distribute Leo Pharma's dermatology products
Baekje Pharmaceutical said that it would exclusively distribute all of Leo ...
by Lee Han-soo  |  2020-06-09 16:49
라인
LegoChem licenses in Covid-19 treatment candidates
LegoChem BioScience licensed in two Covid-19 treatment candidates from the ...
by Lee Han-soo  |  2020-06-09 16:48
라인
MSD Korea’s privacy breach controversy resurfaces
MSD Korea’s “Self-Assurance Program (SAP),” recording conversations of doct...
by Kim Yun-mi  |  2020-06-09 11:26
라인
Korean, US firms in legal battle over Covid-19 vaccine know-how
A legal dispute is underway between American vaccine maker Inovio and VGXI,...
by Lee Han-soo  |  2020-06-08 21:28
여백
여백
여백
Back to Top